The merger proposal between Aster DM Healthcare Ltd and Quality Care India Ltd (QCIL) has progressed closer to completion, as the National Company Law Tribunal (NCLT), Hyderabad Bench, has instructed the companies to organize meetings of shareholders and unsecured trade creditors to obtain approval for the plan.
According to the NCLT ruling, the meetings are scheduled to take place from February 27 to March 13, 2026. This development follows prior approvals from the Competition Commission of India (CCI) and ‘no-objection’ letters from stock exchanges, thereby clearing significant regulatory obstacles for one of India’s largest healthcare sector consolidation deals.
Pending approval from shareholders, creditors, and other statutory requirements, the companies anticipate finalizing the merger by the first quarter of FY2026–27.
After the merger, the new entity—tentatively named Aster DM Quality Care Ltd—will be co-promoted by the Aster promoters and private equity firm Blackstone. It is projected to be among India’s top three hospital chains by capacity, with a nationwide network of over 10,360 beds.
This transaction unites four well-known hospital brands—Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare—creating a diversified platform across various regions and care segments. As of September 30, 2025, Aster DM Healthcare managed over 5,195 beds, while QCIL had a capacity of around 5,165 beds.
In response to the progress, Aster DM Healthcare Founder and Chairman Dr. Azad Moopen stated that the NCLT decision signifies important advancements in the merger process and expressed optimism in obtaining shareholder and creditor approvals. He further noted that the focus post-merger would be on disciplined integration, utilizing complementary clinical expertise, operational efficiencies, and synergies between the two hospital platforms.
In addition to achieving scale, the merged organization has plans for expansion, aiming to increase its bed capacity to approximately 14,715 beds over the forthcoming years. The enhanced balance sheet and operational reach are expected to facilitate investments in advanced medical technologies, digital health platforms, and innovative care delivery models.
This merger occurs during a period when India’s hospital sector is experiencing rapid consolidation, driven by escalating healthcare demand, increased capital needs, and the pursuit of operational efficiencies. Analysts indicate that larger hospital networks are better suited to minimize costs, invest in technology, attract clinical talent, and penetrate underserved markets.
With most regulatory approvals already secured, the forthcoming shareholder and creditor meetings present the last significant hurdle before the merger takes effect, potentially transforming the competitive dynamics of India’s hospital industry.
Also Read: Outlook 2026 | Healthcare — how data, AI, and next‑generation analytics are reshaping patient outcomes
